Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Yaelle Bavli"'
Autor:
Ahuva Cern, Yaelle Bavli, Atara Hod, Daniel Zilbersheid, Shazad Mushtaq, Ayelet Michael-Gayego, Dinorah Barasch, Yael Feinstein Rotkopf, Allon E. Moses, David M. Livermore, Yechezkel Barenholz
Publikováno v:
Pharmaceutics, Vol 13, Iss 12, p 2186 (2021)
Antibiotic resistance is a global health threat. There are a few antibiotics under development, and even fewer with new modes of action and no cross-resistance to established antibiotics. Accordingly, reformulation of old antibiotics to overcome resi
Externí odkaz:
https://doaj.org/article/88f8dd726fd14c7a8535af5349bf0ad5
Publikováno v:
Pharmaceutics, Vol 13, Iss 2, p 185 (2021)
We previously reported the development of a novel formulation of an ultra-long-acting local anesthetic based on bupivacaine encapsulated in large multivesicular liposomes (Bupisomes) embedded in hydrogel. This formulation (Bupigel) prolonged bupivaca
Externí odkaz:
https://doaj.org/article/d7dcb06054fe4e68844feaeb8306ccc4
Autor:
Yaelle Bavli, Bing-Mae Chen, Steve R. Roffler, Marina A. Dobrovolskaia, Eldad Elnekave, Shifra Ash, Yechezkel Barenholz, Keren Turjeman
Publikováno v:
Molecules, Vol 25, Iss 3, p 558 (2020)
PEGylated nanomedicines are known to induce infusion reactions (IRs) that in some cases can be life-threatening. Herein, we report a case study in which a patient with rare mediastinal and intracardiac IgG4-related sclerosing disease received 8 treat
Externí odkaz:
https://doaj.org/article/a4a5ff46d1924662b5c3171c0b42336f
Autor:
Keren Turjeman, Yaelle Bavli, Pablo Kizelsztein, Yaelle Schilt, Nahum Allon, Tamar Blumenfeld Katzir, Efrat Sasson, Uri Raviv, Haim Ovadia, Yechezkel Barenholz
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0130442 (2015)
The present study shows the advantages of liposome-based nano-drugs as a novel strategy of delivering active pharmaceutical ingredients for treatment of neurodegenerative diseases that involve neuroinflammation. We used the most common animal model f
Externí odkaz:
https://doaj.org/article/f5e90184f4de4ffb9c74297707768ce1
Autor:
Yaelle, Bavli, Bing-Mae, Chen, Guy, Gross, Alon, Hershko, Keren, Turjeman, Steve, Roffler, Yechezkel, Barenholz
Publikováno v:
Journal of Controlled Release. 354:316-322
The early and massive vaccination campaign in Israel with the mRNA-LNP Comirnaty® (Pfizer-BioNTech) vaccine against the SARS-CoV-2 virus made available large amounts of data regarding the efficacy and safety of this vaccine. Adverse reactions to mRN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1dfd9494c44e199cbfcb24e4160653d
https://doi.org/10.1016/j.jconrel.2022.12.039
https://doi.org/10.1016/j.jconrel.2022.12.039
Autor:
Tamás Gábor Fülöp, László Rosivall, Tamás Mészáros, Yechezkel Barenholz, Ildikó Vashegyi, Yaelle Bavli, Tom Eirik Mollnes, Janos Szebeni, Gergely Tibor Kozma, Erik Örfi, László Dézsi, Rudolf Urbanics
Publikováno v:
ACS Nano
Polyethylene glycol (PEG)-coated nanopharmaceuticals can cause mild to severe hypersensitivity reactions (HSRs), which can occasionally be life threatening or even lethal. The phenomenon represents an unsolved immune barrier to the use of these drugs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e33b139b5b602fb92e8e5e559bbb7fa
https://doi.org/10.1021/acsnano.9b03942
https://doi.org/10.1021/acsnano.9b03942
Autor:
Rivka Cohen, Yechezkel Barenholz, Bing Mae Chen, Steve R. Roffler, Yaelle Bavli, Janos Szebeni, Ilan Winkler
Publikováno v:
Journal of Controlled Release. 306:138-148
The increasing use in the last decade of PEGylated nanodrugs such as Doxil® has seen a rise in the number of associated occurrences of hypersensitivity reactions (HSRs). These reactions (also called infusion reactions or IR), can range from harmless
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ea24390011b01cfc597022f0e004eb8
https://doi.org/10.1016/j.jconrel.2019.06.007
https://doi.org/10.1016/j.jconrel.2019.06.007
Autor:
Keren Turjeman, Nurit Yanay, Moria Gross, Malcolm Rabie, Yaelle Bavli, Yoram Nevo, M. Elbaz, Yechezkel Barenholz
Publikováno v:
Nanomedicine: Nanotechnology, Biology and Medicine. 16:34-44
Glucocorticosteroids are the most efficacious anti-inflammatory agents and the gold standard treatment in Duchenne muscular dystrophy (DMD). However, their chronic use may lead to severe side effects. We evaluated the use of a novel injectable steroi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c96766ec5be759c8419df2170d3d756
https://doi.org/10.1016/j.nano.2018.11.012
https://doi.org/10.1016/j.nano.2018.11.012
Publikováno v:
Pharmaceutics, Vol 13, Iss 185, p 185 (2021)
Pharmaceutics
Volume 13
Issue 2
Pharmaceutics
Volume 13
Issue 2
We previously reported the development of a novel formulation of an ultra-long-acting local anesthetic based on bupivacaine encapsulated in large multivesicular liposomes (Bupisomes) embedded in hydrogel. This formulation (Bupigel) prolonged bupivaca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5be3b2daf6035b827ff0db2c008fdcac
https://www.mdpi.com/1999-4923/13/2/185
https://www.mdpi.com/1999-4923/13/2/185
Autor:
Bing-Mae Chen, Marina A. Dobrovolskaia, Yechezkel Barenholz, Eldad Elnekave, Shifra Ash, Yaelle Bavli, Steve R. Roffler, Keren Turjeman
Publikováno v:
Molecules
Volume 25
Issue 3
Molecules, Vol 25, Iss 3, p 558 (2020)
Volume 25
Issue 3
Molecules, Vol 25, Iss 3, p 558 (2020)
PEGylated nanomedicines are known to induce infusion reactions (IRs) that in some cases can be life-threatening. Herein, we report a case study in which a patient with rare mediastinal and intracardiac IgG4-related sclerosing disease received 8 treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63b7fdd2d9f2558ab6027c08052e2c1e